Fact checked byKristen Dowd

Read more

October 01, 2024
3 min read
Save

Top news of September: Milk ladder therapy, antibiotic use, AI-sinus mapping app, more

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio has compiled September’s most-read news in asthma and allergy.

Top stories included food allergy, allergic rhinitis and airways resistance treatments; the possible way pre- and post-natal antibiotics use impacts food allergy development; new AI-assisted technology that could help with seasonal allergies; and more.

trujilo

Milk ladder therapy successful in mediating cow’s milk allergy

Dietary advancement therapy using a milk ladder shows that cow’s milk can be safely reintroduced to infants with a cow’s milk allergy, according to a study published in Pediatric Allergy and Immunology. Infants in the milk ladder group were almost four times more likely to be successful in reintroducing cow’s milk. Juan Trujillo, MD, PhD, pediatric allergist at Cork University Hospital and senior lecturer in the department of pediatrics and child health at University College Cork, spoke with Healio about the study results. Kathleen Garcia-Benson, RDN, CSSD, LD, NASM-CPT, NBC-HWC, shares her Perspective. Read more.

Food allergy may be bidirectionally associated with atopic dermatitis

Carina Venter

Children diagnosed with atopic dermatitis or food allergy were more likely to develop either disorder as time went on, according to a study published in Pediatric Allergy and Immunology. By age 4 years, children with atopic dermatitis were five times more likely to develop a food allergy. Healio spoke with Carina Venter, PhD, RD, associate professor of pediatrics at the University of Colorado Denver School of Medicine, Children’s Hospital Colorado, about the implications of the study results. Read more.

Access to care, education may improve early introduction of allergens into infant diets

Healio spoke with Michael Pistiner, MD, MMSc, at the 16th Annual Allergy, Asthma & Immunology CME Conference about obstacles in the prompt introduction of allergenic foods into infant diets. “Barriers to early introductions of allergens are varied and include issues of access to care and access to information,” Pistiner said. Read more.

Q&A: How changing your beliefs can advance your career trajectory

Your mindset and beliefs have a direct impact on your career performance, according to Laura Desveaux, PhD, PT, scientific director and learning health system program lead at Trillium Health Partners’ Institute for Better Health. During her talk at the Women in Medicine Summit, Desveaux discussed how our beliefs directly impact our successes and failures. Read more.

Patients with asthma, obesity experience improved control with GLP-1 RAs

Heath Heatley

Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress. “Obesity is known to be a risk factor for asthma and to be associated with poor asthma control,” Heath Heatley, PhD, senior researcher at Observational and Pragmatic Research Institute, said during his presentation. Susan Cornell, PharmD, CDE, FAPhA, FAADE, shares her Perspective. Read more.

Sublingual immunotherapy effective for young children with allergic rhinitis

Sublingual immunotherapy for house dust mite allergy improved allergic rhinitis symptoms among children aged 1 to 4 years over 12 months, according to a study published in Pediatric Allergy and Immunology. This treatment also induced immunologic changes specific to the allergen and was well tolerated, Koki Sasamoto, PhD, department of allergy, Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, and colleagues wrote. Michael S. Blaiss, MD, FACAAI, FAAAAI, and Nikhila D. Schroeder, MD, MEng, share their Perspectives. Read more.

Depemokimab reduces severe asthma exacerbations by half with twice-yearly treatment

Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European Respiratory Society International Congress. The reduction in dosing frequency compared with other biologic therapies may reduce treatment burden and health care use while improving quality of life, David J. Jackson, PhD, MSc, FRCP, professor of respiratory medicine at King’s College London, and colleagues wrote. John J. Oppenheimer, MD, shares his Perspective. Read more.

Airway resistance improves after periodontal treatment

The next time you have patients who struggle with airway resistance, you may want to refer them to your local periodontist for a deep cleaning, according to a poster presented at the European Respiratory Society International Congress. Healio spoke with Anders Røsland, a PhD candidate in the department of clinical dentistry at the University of Bergen in Norway, about the effects of the treatment. Bruce V. Freeman, DDS, DOrtho, MSc, shares his Perspective. Read more.

Prenatal, postnatal antibiotic use may be associated with food allergy development

Researchers found a moderate association in early life antibiotic use and childhood food allergy in South Korea, according to a study published in Pediatric Allergy and Immunology.

Both prenatal and postnatal antibiotic use showed a 5% increase in subsequent food allergy in children, Jiyeon Oh, MD, of the department of medicine, Kyung Hee University College of Medicine in Seoul, South Korea, and colleagues wrote. Read more.

Q&A: Phone app uses AI technology to personalize allergy forecasts

SoundHealth announced the unveiling of SONUCast, which predicts allergy responses based on the shape and size of a person’s nasal cavity and sinuses. Healio spoke with Paramesh Gopi,MS, PhD, founder and CEO of SoundHealth, about the new app, how it works and how it will help those suffering with allergies. Read more.